Coverage
-
August 11, 2011
GlaxoSmithKline PLC on Wednesday prevailed in a suit alleging it falsely marked the laxative Citrucel with expired patents, with a New York federal judge ruling following a bench trial that there was no evidence the company knew the patents were expired or intended to deceive the public.
1 other articles on this case.
View all »